Growth and Innovation in the Ornithine Transcarbamylase (OTC)...

adicionou um novo artigo Outro

2025-07-29 13:12:54 -

Growth and Innovation in the Ornithine Transcarbamylase (OTC) Deficiency Treatment Market

Ornithine transcarbamylase (OTC) deficiency is a rare, life-threatening genetic disorder that disrupts the body's ability to eliminate ammonia from the blood, primarily affecting the urea cycle. Due to the severity of this condition, the global demand for effective treatment options has seen significant growth. The Ornithine Transcarbamylase (OTC) Deficiency Treatment Market is expected to...

0 Comentários 0 Compartilhamentos 8 Visualizações